Palo Alto Investors LP - MIRUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Palo Alto Investors LP ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,044,520
+22.1%
64,7000.0%0.19%
+43.0%
Q2 2023$1,673,789
+7.7%
64,7000.0%0.14%
+4.7%
Q1 2023$1,554,094
+23.2%
64,7000.0%0.13%
+19.4%
Q4 2022$1,261,650
-7.2%
64,7000.0%0.11%
+0.9%
Q3 2022$1,359,000
+7.9%
64,7000.0%0.11%
-2.7%
Q2 2022$1,259,000
-11.6%
64,7000.0%0.11%0.0%
Q1 2022$1,425,000
+38.1%
64,7000.0%0.11%
+66.7%
Q4 2021$1,032,00064,7000.07%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 1,921,118$38,269,0006.42%
FRAZIER MANAGEMENT LLC 3,566,912$71,053,0005.68%
Novo Holdings A/S 2,445,147$48,707,0002.52%
Sio Capital Management, LLC 248,978$4,960,0001.58%
Mesirow Financial Investment Management, Inc. 25,795$514,0001.51%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,282,912$65,396,0001.28%
NEA Management Company, LLC 4,187,801$83,421,0000.99%
MPM BioImpact LLC 308,532$6,146,0000.95%
Rock Springs Capital Management LP 1,525,623$30,390,0000.64%
BVF INC/IL 435,936$8,684,0000.34%
View complete list of MIRUM PHARMACEUTICALS INC shareholders